INARI MEDICAL INC. -

Inari Medical to Present at Upcoming Investor Conferences

02 Nov 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Reports Third Quarter 2023 Financial Results

01 Nov 2023 16:02:00 By Nasdaq GlobeNewswire

Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow

01 Nov 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Announce Third Quarter 2023 Financial Results

11 Oct 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Present at Upcoming Investor Conferences

24 Aug 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Reports Second Quarter 2023 Financial Results

02 Aug 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Present at the 43rd Annual Canaccord Growth Conference

26 Jul 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Announce Second Quarter 2023 Financial Results

13 Jul 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Announces Commercial Launch of RevCore™ and Triever16 Curve™, Two New Purpose-Built Products for Addressing Venous Stent Thrombosis and Venous Thromboembolism

07 Jun 2023 08:00:01 By Nasdaq GlobeNewswire

Inari Medical Announces the Release of 2022 Ethos and Sustainability Report

25 May 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism Patients

22 May 2023 08:00:01 By Nasdaq GlobeNewswire

Inari Medical Reports First Quarter 2023 Financial Results

03 May 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Present at the Bank of America 2023 Healthcare Conference

02 May 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Announce First Quarter 2023 Financial Results

13 Apr 2023 16:01:00 By Nasdaq GlobeNewswire

FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System

06 Mar 2023 08:00:00 By Nasdaq GlobeNewswire

Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results

27 Feb 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results

07 Feb 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

31 Jan 2023 16:01:00 By Nasdaq GlobeNewswire

Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis

12 Jan 2023 08:00:00 By Nasdaq GlobeNewswire

Inari Medical Announces Preliminary 2022 Revenue and 2023 Guidance

10 Jan 2023 08:00:01 By Nasdaq GlobeNewswire